Randomized control trials on chemoembolization for hepatocellular carcinoma: Is there room for new studies?

Journal of Clinical Gastroenterology

Volumn 32, Issue 5, 2001, Pages 383-389

  Trevisani, Franco ^a,b   De Notariis, Stefania ^a   Rossi, Cristina ^a   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

Chemoembolization; Hepatocellular carcinoma; Randomized control trials

Indexed keywords

CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GELATIN SPONGE; IODINATED POPPYSEED OIL; IODINE 131; MEGLUMINE IOTALAMATE; TAMOXIFEN;

ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; PALLIATIVE THERAPY; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; HUMANS; LIVER NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0035028590     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200105000-00005     Document Type: Review

References (48)

1. Hepatocellular carcinoma. A worldwide problem and the major risk factors
2. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
3. Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents
4. 13I-labeled-iodized oil in the treatment of hepatocellular carcinoma
5. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma
6. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma
7. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial
8. Liver parenchymal changes after transcatheter arterial embolization therapy for hepatoma: CT evaluation
9. Treatment of hepatocellular carcinoma using doxorubicin/ethionized oil/gelatin powder chemoembolization
10. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization: Comparison of planned periodic chemoembolization and chemoembolization based on tumor response
11. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: Local therapeutic effect and 5-year survival rate
12. Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow-up CT and therapeutic results
13. Optimal lipiodol volume in trancatheter arterial chemoembolotherapy for hepatocellular carcinoma: Study based on lipiodol accumulation patterns and histopathologic findings
14. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients
15. Blood supply of early hepatocellular carcinoma
16. Intra-arterial and intravenous use of 4 epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison
17. Chemiothérapie couplée au lipiodol: Etude in vitro de la cinétique de libération de l'Adriamycine
18. Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin
19. Chemoembolization of hepatocellular carcinomas
20. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution
21. Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma
22. Primary treatment of hepatocellular carcinoma by arterial chemoembolization
23. Improved survival with resection after trancatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma
24. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma. A randomized controlled trial
25. Structure and function of the p52 tumor suppression gene: Clues for rational cancer therapeutic strategies
26. Hepatocellular carcinoma cells during anoxia by preventing phospholipase-mediated calpain activation
27. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization
28. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
29. Comparison of resection, liver transplantation and transcatheter oily chemoembolization in the treatment of hepatocellular carcinoma
30. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients
31. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
32. Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: Results a western comparative study in 60 patients
33. Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment
34. Percutaneous ethanol injection for patients with small hepatocellular carcinoma
35. Transcatheter arterial chemoembolization in hepatocellular carcinoma
36. Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors and tumor growth rate and patient survival
37. No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis
38. Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization
39. Bile duct cysts secondary to liver infarcts: Report of a case and experimental production of small vessel hepatic artery occlusion
40. Alcohol consumption influences the survival of patients with hepatocellular carcinoma treated with endoarterial therapy
41. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction
42. Power doppler sonography: Evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy
43. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
44. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis
45. Evaluation of transcatheter arterial chemoembolization and ethanol injection for advanced hepatocellular carcinoma
46. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection. A single-center analysis including 132 patients
47. Treatment of large HCC: Transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization